Oliver Luxxe Assets LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1666239 GLADSTONE, NJ

Position in REGN

as of Mar 31, 2026 · filed Apr 8, 2026 Compact

Position Value

$3,585,822

-$945,334 QoQ

Shares Held

4,641

-35.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Oliver Luxxe Assets LLC holds $10,072,172 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	18,860	$4,544,694
2	HALO	Halozyme Therapeutics, Inc.	33,014	$2,584,005
3			49,744	$1,563,453
4	INVA	Innoviva, Inc.	58,957	$1,338,913
5	GANX	Gain Therapeutics, Inc.	20,250	$41,107

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,585,822	4,641	-35.3%	Shares	Sole	2026-04-08
2021-12-31	$4,531,156	7,175	0.0%	Shares	Sole	2022-02-04
2021-09-30	$4,342,166	7,175	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.